NYSE:WST

West Pharmaceutical Services Stock Forecast, Price & News

$411.73
+6.81 (+1.68 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$403.49
$413.22
50-Day Range
$330.30
$411.73
52-Week Range
$253.85
$413.22
Volume679,866 shs
Average Volume347,787 shs
Market Capitalization$30.39 billion
P/E Ratio60.19
Dividend Yield0.17%
Beta0.99
30 days | 90 days | 365 days | Advanced Chart
Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.


West Pharmaceutical Services logo

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.41 out of 5 stars

Analyst Opinion: 1.3Community Rank: 3.7Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

Is West Pharmaceutical Services a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" West Pharmaceutical Services stock.
View analyst ratings for West Pharmaceutical Services
or view top-rated stocks.

What stocks does MarketBeat like better than West Pharmaceutical Services?

Wall Street analysts have given West Pharmaceutical Services a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but West Pharmaceutical Services wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 967,000 shares, a decline of 13.7% from the June 30th total of 1,120,000 shares. Based on an average trading volume of 379,000 shares, the days-to-cover ratio is presently 2.6 days. Approximately 1.3% of the shares of the stock are sold short.
View West Pharmaceutical Services' Short Interest
.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for West Pharmaceutical Services
.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) issued its quarterly earnings results on Thursday, July, 29th. The medical instruments supplier reported $2.46 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.74 by $0.72. West Pharmaceutical Services had a trailing twelve-month return on equity of 29.50% and a net margin of 20.58%.
View West Pharmaceutical Services' earnings history
.

How has West Pharmaceutical Services' stock been impacted by COVID-19?

West Pharmaceutical Services' stock was trading at $147.83 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, WST stock has increased by 178.5% and is now trading at $411.73.
View which stocks have been most impacted by COVID-19
.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Wednesday, May 5th. Shareholders of record on Wednesday, July 21st will be paid a dividend of $0.17 per share on Wednesday, August 4th. This represents a $0.68 annualized dividend and a yield of 0.17%. The ex-dividend date is Tuesday, July 20th.
View West Pharmaceutical Services' dividend history
.

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services pays an annual dividend of $0.68 per share and currently has a dividend yield of 0.17%. West Pharmaceutical Services has been increasing its dividend for 25 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of West Pharmaceutical Services is 14.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 8.77% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.
View West Pharmaceutical Services' dividend history.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2021 earnings guidance on Thursday, July, 29th. The company provided EPS guidance of $8.050-$8.200 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.140. The company issued revenue guidance of $2.76 billion-$2.79 billion, compared to the consensus revenue estimate of $2.68 billion.

What price target have analysts set for WST?

2 brokers have issued 1-year price objectives for West Pharmaceutical Services' stock. Their forecasts range from $300.00 to $475.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $387.50 in the next twelve months. This suggests that the stock has a possible downside of 5.9%.
View analysts' price targets for West Pharmaceutical Services
or view top-rated stocks among Wall Street analysts.

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the following people:
  • Mr. Eric M. Green, Pres, CEO & Director (Age 51, Pay $3.1M)
  • Mr. Bernard J. Birkett, Sr. VP & CFO (Age 52, Pay $1.46M)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 56, Pay $1.04M)
  • Mr. Silji Abraham, Sr. VP & Chief Technology Officer (Age 49, Pay $1.03M)
  • Mr. Chad R. Winters, VP, Chief Accounting Officer & Corp. Controller (Age 42)
  • Dr. Quintin J. Lai C.F.A., Ph.D., VP of Corp. Devel., Strategy & Investor Relations (Age 54)
  • Ms. Kimberly Banks MacKay, Sr. VP, Gen. Counsel & Company Sec. (Age 55)
  • Michele Pelkowski, VP of Global Communications
  • Ms. Annette F. Favorite, Chief HR Officer & Sr. VP (Age 56)
  • Mr. Richard D. Luzzi, Sr. VP of HR (Age 69)

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services CEO Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among West Pharmaceutical Services' employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), The Walt Disney (DIS), The Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of retail and institutional investors. Top institutional investors include Fisher Asset Management LLC (0.39%), Intermede Investment Partners Ltd (0.30%), Alliancebernstein L.P. (0.14%), Conestoga Capital Advisors LLC (0.14%), State of Alaska Department of Revenue (0.05%) and Whittier Trust Co. (0.03%). Company insiders that own West Pharmaceutical Services stock include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner and Silji Abraham.
View institutional ownership trends for West Pharmaceutical Services
.

Which institutional investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Oregon Public Employees Retirement Fund, Intermede Investment Partners Ltd, Alliancebernstein L.P., State of Alaska Department of Revenue, Sound Financial Strategies Group LLC, Security Asset Management, and Harel Insurance Investments & Financial Services Ltd.. Company insiders that have sold West Pharmaceutical Services company stock in the last year include George Lloyd Miller, and Silji Abraham.
View insider buying and selling activity for West Pharmaceutical Services
or view top insider-selling stocks.

Which institutional investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including Bright Rock Capital Management LLC, CBOE Vest Financial LLC, Conestoga Capital Advisors LLC, Arkadios Wealth Advisors, Marshall Financial Group LLC, Whittier Trust Co., IFM Investors Pty Ltd, and Heartland Bank & Trust Co.
View insider buying and selling activity for West Pharmaceutical Services
or or view top insider-buying stocks.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $411.73.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services has a market capitalization of $30.39 billion and generates $2.15 billion in revenue each year. The medical instruments supplier earns $346.20 million in net income (profit) each year or $4.76 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

West Pharmaceutical Services employs 9,200 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?

The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..

When was West Pharmaceutical Services founded?

West Pharmaceutical Services was founded in 1923.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is www.westpharma.com.

Where are West Pharmaceutical Services' headquarters?

West Pharmaceutical Services is headquartered at 530 HERMAN O. WEST DRIVE, EXTON PA, 19341.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.